Payment overview · 2025
General Payments
$292.99
15 reported records · 8 companies
Healthcare provider profile · identity verified
James E Kenney, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · HENDERSON, NC · NPI 1639177249
Verified facts
What the public records show
CMS Open Payments records show James E Kenney, M.D. received $292.99 in general payments during 2025 across 15 reported records.
GlaxoSmithKline, LLC. accounted for 31.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 8 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 38 claims for Linzess by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 113 claims for Trelegy Ellipta by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 114 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $91.74 | 31.3% | 5 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $57.95 | 19.8% | 3 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $35.15 | 12.0% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $24.50 | 8.4% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$23.01 | 7.8% | 1 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $21.83 | 7.5% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $20.67 | 7.0% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $18.14 | 6.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $292.99 | 15 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $91.74 | 5 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $57.95 | 3 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $35.15 | 2 | 2025 |
Source payment records
|
|||||
| KRYSTEXXA Normalized: krystexxa |
Biological | Amgen Inc. | $24.50 | 1 | 2025 |
Source payment records
|
|||||
| INCEPTIV Normalized: inceptiv |
Device | Medtronic, Inc. | $23.01 | 1 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $21.83 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $20.67 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $18.14 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 113 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
38 | suppressed by CMS |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
113 | 34 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
114 | 35 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1369 | 325 |
| Amlodipine Besylate | Amlodipine Besylate | 1125 | 295 |
| Eliquis | Apixaban | 759 | 84 |
| Furosemide | Furosemide | 718 | 190 |
| Gabapentin | Gabapentin | 709 | 160 |
| Omeprazole | Omeprazole | 596 | 149 |
| Tamsulosin Hcl | Tamsulosin Hcl | 589 | 116 |
| Metformin Hcl | Metformin Hcl | 580 | 128 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 541 | 142 |
| Lisinopril | Lisinopril | 510 | 121 |
| Pantoprazole Sodium | Pantoprazole Sodium | 476 | 125 |
| Potassium Chloride | Potassium Chloride | 473 | 115 |
| Losartan Potassium | Losartan Potassium | 424 | 107 |
| Hydrochlorothiazide | Hydrochlorothiazide | 401 | 99 |
| Metoprolol Succinate | Metoprolol Succinate | 365 | 87 |
| Clopidogrel | Clopidogrel Bisulfate | 332 | 62 |
| Ibuprofen | Ibuprofen | 331 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 322 | 74 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 313 | 118 |
| Fluticasone Propionate | Fluticasone Propionate | 282 | 89 |
| Sertraline Hcl | Sertraline Hcl | 262 | 54 |
| Allopurinol | Allopurinol | 245 | 57 |
| Carvedilol | Carvedilol | 241 | 55 |
| Levetiracetam | Levetiracetam | 237 | 40 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 235 | 50 |
| Metoprolol Tartrate | Metoprolol Tartrate | 234 | 61 |
| Divalproex Sodium | Divalproex Sodium | 218 | 30 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 214 | 66 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 214 | 107 |
| Glipizide Er | Glipizide | 206 | 55 |
| Metformin Hcl Er | Metformin Hcl | 204 | 51 |
| Prednisone | Prednisone | 200 | 121 |
| Simvastatin | Simvastatin | 199 | 49 |
| Trazodone Hcl | Trazodone Hcl | 196 | 49 |
| Glipizide | Glipizide | 194 | 58 |
| Jardiance | Empagliflozin | 194 | 36 |
| Donepezil Hcl | Donepezil Hcl | 192 | 46 |
| Hydralazine Hcl | Hydralazine Hcl | 184 | 52 |
| Tramadol Hcl | Tramadol Hcl | 181 | 85 |
| Valsartan | Valsartan | 181 | 44 |
| Quetiapine Fumarate | Quetiapine Fumarate | 169 | 40 |
| Torsemide | Torsemide | 164 | 31 |
| Latanoprost | Latanoprost | 162 | 29 |
| Verapamil Er | Verapamil Hcl | 158 | 48 |
| Alprazolam | Alprazolam | 149 | 47 |
| Mirtazapine | Mirtazapine | 147 | 37 |
| Humalog Kwikpen U-100 | Insulin Lispro | 142 | 32 |
| Chlorthalidone | Chlorthalidone | 131 | 36 |
| Clonidine Hcl | Clonidine Hcl | 131 | 28 |
| Lactulose | Lactulose | 128 | 22 |
| Xarelto | Rivaroxaban | 126 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 121 | 44 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 115 | 41 |
| Escitalopram Oxalate | Escitalopram Oxalate | 115 | 19 |
| Mupirocin | Mupirocin | 115 | 68 |
| Ozempic | Semaglutide | 114 | 35 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 113 | 34 |
| Fluoxetine Hcl | Fluoxetine Hcl | 108 | 27 |
| Spironolactone | Spironolactone | 106 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 105 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 104 | 24 |
| Colchicine | Colchicine | 102 | 30 |
| Novolog Flexpen | Insulin Aspart | 100 | 22 |
| Baclofen | Baclofen | 98 | 16 |
| Farxiga | Dapagliflozin Propanediol | 98 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 96 | 15 |
| Risperidone | Risperidone | 95 | 18 |
| Lorazepam | Lorazepam | 88 | 22 |
| Pregabalin | Pregabalin | 88 | 24 |
| Amoxicillin | Amoxicillin | 87 | 69 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 83 | 28 |
| Naproxen | Naproxen | 80 | 20 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 80 | suppressed |
| Nystatin | Nystatin | 79 | 29 |
| Finasteride | Finasteride | 77 | 14 |
| Januvia | Sitagliptin Phosphate | 77 | 21 |
| Symbicort | Budesonide/Formoterol Fumarate | 76 | 18 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 75 | 25 |
| Azithromycin | Azithromycin | 74 | 65 |
| Benztropine Mesylate | Benztropine Mesylate | 72 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 72 | 66 |
| Cephalexin | Cephalexin | 71 | 53 |
| Meclizine Hcl | Meclizine Hcl | 71 | 22 |
| Memantine Hcl | Memantine Hcl | 71 | 17 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 70 | 16 |
| Montelukast Sodium | Montelukast Sodium | 69 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 68 | 52 |
| Midodrine Hcl | Midodrine Hcl | 67 | 15 |
| Sevelamer Carbonate | Sevelamer Carbonate | 67 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 66 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 64 | 16 |
| Myrbetriq | Mirabegron | 63 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 62 | 16 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 62 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 58 | 17 |
| Aripiprazole | Aripiprazole | 58 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 57 | 18 |
| Atenolol | Atenolol | 56 | 17 |
| Breo Ellipta | Fluticasone/Vilanterol | 56 | 13 |
| Brimonidine Tartrate | Brimonidine Tartrate | 55 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 54 | suppressed |
| Bupropion Xl | Bupropion Hcl | 53 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 53 | 12 |
| Fluconazole | Fluconazole | 52 | 31 |
| Ropinirole Hcl | Ropinirole Hcl | 52 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 12 |
| Buspirone Hcl | Buspirone Hcl | 50 | suppressed |
| Clonazepam | Clonazepam | 50 | 12 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 50 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 50 | 30 |
| Olanzapine | Olanzapine | 49 | 15 |
| Topiramate | Topiramate | 49 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 48 | 12 |
| Ezetimibe | Ezetimibe | 48 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 48 | 41 |
| Oxybutynin Chloride | Oxybutynin Chloride | 48 | 13 |
| Sucralfate | Sucralfate | 47 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 46 | 13 |
| Ketoconazole | Ketoconazole | 46 | 20 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 45 | suppressed |
| Lamotrigine | Lamotrigine | 44 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 44 | 13 |
| Diltiazem 24hr Er | Diltiazem Hcl | 43 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 43 | 18 |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Linzess | Linaclotide | 38 | suppressed |
| Nifedipine Er | Nifedipine | 38 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 38 | 15 |
| Ramipril | Ramipril | 38 | suppressed |
| Haloperidol | Haloperidol | 37 | suppressed |
| Ibu | Ibuprofen | 37 | 12 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 37 | suppressed |
| Famotidine | Famotidine | 36 | 12 |
| Lacosamide | Lacosamide | 35 | suppressed |
| Meloxicam | Meloxicam | 35 | 14 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 34 | 33 |
| Metoclopramide Hcl | Metoclopramide Hcl | 34 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 33 | suppressed |
| Calcium Acetate | Calcium Acetate | 32 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 30 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 29 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 29 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 29 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 28 | suppressed |
| Risperidone Odt | Risperidone | 28 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 28 | suppressed |
| Acyclovir | Acyclovir | 27 | suppressed |
| Celecoxib | Celecoxib | 27 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 27 | suppressed |
| Telmisartan | Telmisartan | 26 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 25 | suppressed |
| Clotrimazole | Clotrimazole | 24 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 24 | 14 |
| Felodipine Er | Felodipine | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Paliperidone Er | Paliperidone | 24 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Primidone | Primidone | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 23 | suppressed |
| Humulin R | Insulin Regular, Human | 23 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 23 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 22 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 22 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 22 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 22 | 11 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Hydrocortisone | Hydrocortisone | 21 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Propafenone Hcl Er | Propafenone Hcl | 21 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 20 | 20 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 20 | suppressed |
| Exemestane | Exemestane | 20 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 20 | suppressed |
| Levofloxacin | Levofloxacin | 20 | 17 |
| Dapagliflozin | Dapagliflozin Propanediol | 19 | suppressed |
| Entresto | Sacubitril/Valsartan | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 18 | suppressed |
| Methocarbamol | Methocarbamol | 18 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 18 |
| Phenobarbital | Phenobarbital | 18 | suppressed |
| Procrit | Epoetin Alfa | 18 | suppressed |
| Tivicay | Dolutegravir Sodium | 18 | suppressed |
| Tradjenta | Linagliptin | 18 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Cilostazol | Cilostazol | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Glucagon Emergency Kit | Glucagon | 16 | suppressed |
| Verapamil Sr | Verapamil Hcl | 16 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 15 | 11 |
| Verapamil Hcl | Verapamil Hcl | 15 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 14 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 14 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Novolog | Insulin Aspart | 14 | suppressed |
| Ondansetron Odt | Ondansetron | 14 | 12 |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Fluorometholone | Fluorometholone | 13 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Zonisamide | Zonisamide | 13 | suppressed |
| Brinzolamide | Brinzolamide | 12 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Glimepiride | Glimepiride | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | 11 |
| Restasis | Cyclosporine | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 12 | suppressed |
| Trandolapril | Trandolapril | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Ciclopirox | Ciclopirox | 11 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 11 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 11 | suppressed |
| Enulose | Lactulose | 11 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 11 | suppressed |
| Metronidazole | Metronidazole | 11 | 11 |
| Minoxidil | Minoxidil | 11 | suppressed |
| Mitigare | Colchicine | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $292.99 · 15 records | GlaxoSmithKline, LLC. | CAPLYTA, INCEPTIV, KRYSTEXXA, Korlym, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, VRAYLAR, Wegovy | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error